Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Drugs: cardiovascular system

Statins are not associated with a decrease in all cause mortality in a high-risk primary prevention setting
Bernhard M Kaess, Ramachandran S Vasan

BMJ Evidence-Based Medicine Feb 2011, 16 (1) 8-9; DOI: 10.1136/ebm1125
Foot temperature monitoring at home reduced foot complications in high risk patients with diabetes
BMJ Evidence-Based Medicine Jun 2005, 10 (3) 86; DOI: 10.1136/ebm.10.3.86
A computer based decision support system and risk chart did not reduce cardiovascular risk or blood pressure in hypertension
BMJ Evidence-Based Medicine Jan 2001, 6 (1) 9; DOI: 10.1136/ebm.6.1.9
Beyond genetics: focusing on maternal environment for congenital heart disease prevention
Vidu Garg, Madhumita Basu

BMJ Evidence-Based Medicine Apr 2014, 19 (2) e8; DOI: 10.1136/eb-2013-101556
In hypertensive patients with elevated risk of cardiovascular disease, targeting systolic blood pressure to less than 120 mm Hg significantly reduces the rate of fatal and non-fatal cardiovascular events as well as death from any cause
Mina Owlia, Sripal Bangalore

BMJ Evidence-Based Medicine Jun 2016, 21 (3) 101; DOI: 10.1136/ebmed-2016-110397
Tamoxifen reduced breast cancer risk but increased risks of thromboembolic events and all cause mortality in women
BMJ Evidence-Based Medicine Jul 2003, 8 (4) 110; DOI: 10.1136/ebm.8.4.110
Review: long-term β-blocker use reduces mortality after myocardial infarction
BMJ Evidence-Based Medicine Jan 2000, 5 (1) 12; DOI: 10.1136/ebm.5.1.12
Valsartan is more effective than placebo in reducing the incidence of diabetes in people with impaired glucose tolerance and cardiovascular disease or risk factors but has no effect on cardiovascular outcomes
Yves Lacourcière, Luc Poirier

BMJ Evidence-Based Medicine Aug 2011, 16 (4) 122-123; DOI: 10.1136/ebm1412
Evidently...
Richard Lehman

BMJ Evidence-Based Medicine Oct 2007, 12 (5) 135; DOI: 10.1136/ebm.12.5.135
Long term use of eicosapentaenoic acid reduced major coronary events in hypercholesterolaemia
BMJ Evidence-Based Medicine Oct 2007, 12 (5) 136; DOI: 10.1136/ebm.12.5.136

Pages